Rate per 100,000 Population of Reported Cases by Age Group - 2011

  <1 1-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60+ Total
AIDS* 0.8 0.0 0.0 0.5 1.1 7.5 11.6 13.5 9.9 3.4 6.6
AMEBIASIS 0.0 0.8 0.3 0.8 1.4 0.9 1.2 1.5 1.2 0.7 1.0
ANAPLASMOSIS 0.0 0.4 1.4 1.1 0.8 1.0 1.6 2.3 4.6 6.1 2.8
BABESIOSIS 0.0 0.2 0.1 0.5 0.5 0.6 1.6 1.8 5.0 9.2 3.2
BOTULISM 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.02
CAMPYLOBACTERIOSIS 36.6 31.2 11.7 8.7 16.3 20.6 17.3 16.8 19.3 19.7 18.3
CHLAMYDIA NA NA NA 60.7 1509.0 1412.5 254.4 53.5 14.9 2.0 334.7
CHOLERA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.04 0.02
CRYPTOSPORIDIOSIS 0.0 9.5 3.0 1.2 3.1 3.8 2.7 1.0 0.9 0.3 2.1
CYCLOSPORA 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1
DENGUE FEVER 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1
E. COLI 0157 2.4 2.7 2.0 1.5 1.6 0.6 0.4 0.4 0.4 0.8 0.9
EHEC** 3.3 4.9 1.9 2.0 1.8 1.4 0.5 0.2 0.5 0.5 1.1
EHRLICHIOSIS 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.2 1.2 0.4
EHRLICHIOSIS/ANAPLASMOSIS UNDETERMINED 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.1
ENCEPHALITIS (NON-WESTNILE) 0.0 0.8 0.4 0.5 0.2 0.1 0.4 0.2 0.4 0.7 0.4
GIARDIASIS 3.3 23.9 13.9 8.6 7.8 9.1 8.6 10.6 10.9 8.5 10.2
GONORRHEA NA NA NA 7.0 200.5 221.7 65.2 21.7 8.2 1.7 55.7
HAEMOPHILUS INFLUENZAE 5.7 0.4 0.4 0.1 0.1 0.4 0.4 0.5 1.5 6.0 1.7
HANTAVIRUS 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.01
HEMOLYTIC UREMIC SYNDROME 0.8 0.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1
HEPATITIS A 0.0 0.4 0.3 0.1 0.4 0.8 0.6 0.4 0.4 0.3 0.4
HEPATITIS B - ACUTE 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.8 0.9 0.6 0.5
HEPATITIS C - ACUTE 0.0 0.0 0.0 0.0 0.0 1.4 0.7 0.4 0.3 0.2 0.4
HIV*** 1.6 0.0 0.0 0.3 6.1 19.2 17.8 14.3 11.2 2.8 9.3
LABORATORY CONFIRMED INFLUENZA 510.4 302.6 257.4 116.8 83.9 116.4 85.5 65.1 53.1 92.8 115.3
LEGIONELLOSIS 0.0 0.0 0.1 0.0 0.1 0.4 1.4 3.4 5.3 10.1 3.6
LISTERIOSIS 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.2 1.6 0.4
LYMPHOGRANULOMA VENEREUM NA NA NA 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.04
MALARIA 0.8 0.4 0.4 0.6 1.0 1.0 0.7 0.5 0.5 0.1 0.5
MEASLES 0.8 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.10
MENINGITIS ASEPTIC 84.7 1.0 5.5 4.8 7.5 5.4 5.6 3.9 2.3 2.2 4.9
MENINGOCOCCAL 0.8 0.2 0.1 0.0 0.1 0.3 0.1 0..1 0.3 0.4 0.2
MENINGITIS OTHER BACT. AND UNKNOWN 4.9 0.0 0.0 0.4 0.5 0.1 0.3 0.2 0.5 0.7 0.5
MUMPS 0.8 0.6 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1
PERTUSSIS 64.3 19.2 25.2 49.0 10.6 1.0 2.1 2.2 1.5 0.9 8.3
Q FEVER 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.05
RMSF 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.1
SALMONELLOSIS 39.1 28.7 13.2 9.3 12.2 13.0 11.3 9.9 11.2 12.6 12.7
SHIGELLOSIS 6.5 30.3 7.2 1.2 1.6 2.1 1.1 1.2 1.5 1.0 3.4
STREP GROUP A INVASIVE 4.1 1.9 2.8 0.0 0.4 1.5 2.0 2.7 3.4 9.0 3.5
STREP GROUP B INVASIVE 40.7 0.4 0.3 0.0 0.2 1.6 2.6 4.2 10.2 25.7 8.4
STREP PNEUMONIA INVASIVE**** 10.6 8.3 3.5 1.6 0.7 1.8 4.0 7.8 10.9 30.6 10.6
SYPHILIS EARLY NA NA NA 0.1 2.6 8.2 6.0 5.3 2.1 0.5 3.1
SYPHILIS LATE NA NA NA 0.0 0.5 3.0 6.0 8.8 7.8 5.1 4.6
TOXIC SHOCK SYNDROME 0.0 0.2 0.0 0.4 0.1 0.0 0.1 0.4 0.2 0.6 0.3
TRICHINOSIS 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.01
TUBERCULOSIS 1.6 1.7 0.1 0.4 1.2 2.9 3.0 1.9 1.8 2.5 2.0
TYPHOID FEVER 0.0 0.6 0.4 0.3 0.1 0.1 0.2 0.1 0.1 0.0 0.1
VIBRIO - NON CHOLERA 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.5 0.7 0.3
VISA 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.6 0.2
WEST NILE FEVER 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1
WEST NILE VIRUS 0.0 0.0 0 0 0 0 0.2 0.2 0.2 0.6 0.2
YERSINIOSIS 0.8 0.2 0 0.1 0.5 0.1 0.4 0.3 0.2 1 0.4

Footnotes

  • * Based on year reported (excludes inmates). Includes all newly-reported AIDS cases regardless of HIV diagnosis date.
    Provisional, data as of September 10, 2012. County of residence is unknown for 4 cases.
  • **E.coli non-O157 and non-sero-grouped shigatoxin producing infection
  • *** Based on year reported (excludes inmates). Includes all newly-reported HIV cases, regardless of concurrent or subsequent AIDS diagnosis.
    Provisional, data as of September 10, 2012.
  • ****Resistant, Sensitive, Intermediate, & Unknown